MOB1A and colorectal cancer: Dysregulation of MOB1A has been reported in several malignant tumors, including colorectal cancer, glioblastoma, intrahepatic cholangiocarcinoma, non-small cell lung cancer, and gallbladder carcinoma [7–11].